obesity treatment

Eli Lilly announced promising results for orforglipron, a once-daily weight-loss pill that helped patients with diabetes lose up to 8% of their body weight in trials. The GLP-1 drug, which avoids injections like Wegovy and Zepbound, could reshape the obesity treatment market. Side effects are similar to injectable options. With FDA approval expected in late […]